The Centre for Aging + Brain Health Innovation (CABHI) is excited to launch its third round of the I2P2 program.
GlycoNet, along with partner institutions, recently awarded more than $3.5M in grants to fund exploratory research in the area of glycomics to benefit human health.
Freezing things is an imperfect process whether freezing food or freezing cells.
Specializing in boxes, cartons and paper packaging, Inkubate Packaging hope to capitalize on their experience in the hemp industry, with the new marijuana industry.
OncoQuest is a biopharmaceutical company focused on the development and commercialization of immunotherapeutic products for the treatment of cancer.
Two U of A professors receive a one year research grant to study 'sugars in biology' which may unlock clues about Alzheimer's, a disease that affects more than 25,000 Canadians, annually.
Lowen’s Natural Skincare is pleased to announce that it has undertaken a brand refresh with its partners at the marketing agency Local Propeller.
Advancing the success of emerging health technologies to save and improve lives globally.
Madenco, a subsiduary of Quest Pharmatech, announce a licensing agreement with Stanford University, for patented EGF wound healing technology.
KMT Hepatech, Inc., a part of PhoenixBio group, announced plans to expand staff and operations by providing services with PXB-Mouse® and starting the production of the PXB-Cells® – hepatocytes isolated from cDNA-uPA/SCID mice with highly humanized liver.
ViaGen has been cloning livestock for more than 15 years, and have recently turned their attention to cloning dogs and cats.
Genomics testing is now practical for crossbred herds, says Delta Genomics.
Cielo Announces a Significant Transaction as it Closes its Previously Announced $3.5M Credit Facility to Fund Renewable Diesel Refinery.
Thursday, November 16, 2017
... carry hidden costs, "Research, innovation goals could be adversely affected." says Mel Wong, BioAlberta's President & CEO.
New biotech spinoff with roots in a GlycoNet project is planning to capitalize on the discovery of a novel cancer-specific sugar to develop new diagnostic tools and drugs for prostate cancer.
Aquila Diagnostics is pleased to announce results of an independent laboratory trial for its point-of-care AccutasVET Tapeworm DNA test.
a new initiative to increase job-readiness of post-secondary STEM (science, technology, engineering, mathematics) and business students across Canada.
The Canada-Alberta Job Grant (CAJG) is a funding program where employers and government share the cost of training new and existing employees to increase their knowledge and skills to meet the needs of Alberta’s changing economy.